پروفایل استاد

. Fe3+-Tryptophan-3-Hydroxy-2-Methyl or ethyl pyridinones Towards Novel Molecular Tumor Nuclear Resonance Imaging Agents

Authors: Ali Khalaj, Shadi Hosseini, Rahimeh Rasouli, Artin Assadi, Seyedeh Ghoreishi and Mehdi Shafiee Ardestani

Letters in Drug Design & Discovery, Year. 2016,

2. Preparation and Biological Study of 68Ga-DOTA-alendronate

Authors: Ashraf Fakhari, Amir R. Jalilian, Fariba Johari-Daha, Mehdi Shafiee-Ardestani, and Ali Khalaj

Asia Ocean J Nucl Med Biol, Year. 2016,

3. Preparation and preclinical evaluation of 68Ga-DOTA-amlodipine for L-type calcium channel imaging

Authors: Tahereh Firuzyar, Amir Reza Jalilian, Mohammad Reza Aboudzadeh, Hossein Sadeghpour, Mahdi Shafiee-Ardestani, Ali Khalaj

IJNM, Year. 2016,

4. Preparation of a 153Sm-5,10,15,20-tetrakis(4-methoxyphenyl) porphyrin complex as a possible therapeutic agent

Authors: Nasim Vahidfar, Amir Reza Jalilian, Yousef Fazaeli, Ali Bahrami-Samani, Davood Beiki, Ali Khalaj

Iranian Journal of Nuclear Medicine, Year. 2015,

5. Production, quality control, biodistribution assessment and preliminary dose evaluation of 166Ho-alendronate as a bone marrow ablative agent

Authors: Ashraf Fakhari, Amir Reza Jalilian, Hassan Yousefnia, Samaneh Zolghadri, Ali Bahrami Samani, Mahmoud Reza Akbari, Fariba Johari Deha, Mahdi Shafiee-Ardestani, Ali Khalaj

International Journal for chemical aspects of nuclear science and technology, Year. 2015,

6. Preparation and preliminary biological evaluation of [153Sm] samarium AMD3100; towards a possible therapeutic chemokine receptor CXCR4 targeting complex

Authors: Ayuob Aghanejad, Amir Reza Jalilian, Ali Bahrami-Samani, Davood Beiki, Stephan Maus, Ali Khalaj

Iranian Journal of Nuclear Medicine, Year. 2015,

7. Radiosynthesis and Animal Studies of 111In-DTPA-bis-alendronate Complex

Authors: Ashraf Fakhari, Amir R. Jalilian, Mahdi Shafiee Ardestani, Fariba Johari Deha, Mohammad Mirzaie, Sedigheh Moradkhan, Ali Khalaj

Biomedical Technologies , Year. 2015,

8. Development of Radiolanthanide-Labeled-Bis- Alendronate Complexes for Bone Pain Palliation Therapy

Authors: Fakhari A, Jalilian AR, Yousefnia H, Shafiee- Ardestani M, Johari-Daha F, Mazidi M and Khalaj A

                                                                                    J Nucl Med Radiother, Year. 2015,

9. Radiolabeling and evaluation of two 177Lu-labeled bis-phosphonates

Authors: Ashraf Fakhari, Amir R.Jalilian, Hassan Yousefnia, Ali Bahrami-Samani; Fariba Johari-Daha, Ali Khalaj

Iranian Journal of Nuclear Medicine, Year. 2015,

10. Preparation, Biological Evaluation and Dosimetry Studies of 175Yb-Bis-Phosphonates for Palliative Treatment of Bone Pain

Authors: Ashraf Fakhari, Amir R.Jalilian, Hassan Yousefnia,, Shanehsazzadeh S, Samani AB, Daha FJ, Ardestani MS, Khalaj A

Mol Imaging Radionucl Ther, Year. 2015,

11. Development of 166Ho-pamidronate for bone pain palliation therapy

Authors: Ashraf Fakhari, Amir R.Jalilian, Hassan Yousefnia, Fariba Johari –Daha, Mohammad Mazidi, Ali Khalaj

J Radioanaly Nuclear Chem , Year. 2014,

12. Effect Of Hydrophilic SolventsS On Enhancing Transdermal Delivery of Albumin

Authors: Narges Shokri, Hamid Akbari Javar, Ali Khalaj

IJPSR, Year. 2014,

13. Preparation and radiolabeling of a lyophilized (kit) formulation of DOTA-rituximab with 90Y and 111In for domestic radioimmunotherapy and radioscintigraphy of Non-Hodgkin’s Lymphoma

Authors: Nazila Gholipour, Amir Reza Jalilian, Ali Khalaj, Fariba Johari-Daha

DARU Journal of Pharmaceutical Sciences, Year. 2014,

14. Preparation and preliminary biological evaluation of radioligand – labeled DTPA –amlodipine complex for possible L-type Calcium channel imaging

Authors: Tahereh Firouzyar,Amir R. Jalillian,Yousef Fazeli, Mohammad Shafiee Ardestani, Mohammad Reza Aboudzadeh,and Ali Khalaj

Radiochimica Acta , Year. 2014,

15. Development of [62Zn/62Cu]-DOTA-rituximab as a possible novel in vivo PET generator for anti-CD20 antigen imaging

Authors: Nazila Gholipour / Amir R. Jalilian / Yousef Fazaeli / Omid Sabzevari/ Sedigheh Moradkhani/ Fateme Bolourinovin/ Ali Khalaj

Radiochimica Acta, Year. 2014,

16. Radiosynthesis and biodistribution studies of [62Zn/62Cu]–plerixafor complex as a novel in vivo PET generator for chemokine receptor imaging

Authors: Ayuob Aghanezhad, Amir R Jalilian, Yousef Fazaeli, Davood beiki, Behrooz Fateh, Ali Khalaj

Journal of Radioanalytical and Nuclear Chemistry, Year. 2014,

17. Synthesis and Evaluation of [(67)Ga]-AMD3100: A Novel Imaging Agent for Targeting the Chemokine Receptor CXCR4.

Authors: Aghanejad A, Jalilian AR, Fazaeli Y2, Alirezapoor B, Pouladi M, Beiki D, Maus S Khalaj A

Sci.Pharm, Vol.82, No.1, Year. 2014, Number of Page:13

18. Radiosynthesis and biological evaluation of 166Ho labeled

Authors: • Nasim Vahidfar,Amir R.Jalilian,Yousef Fazaeli,Ali Bahrami Samani,Davood Beiki, Ali Khalaj

J Radioanal Nucl Chem, Vol.301, Year. 2013, Page:269-276,

19. Development of radiolanthanide labeled porphyrin complexes as possible therapeutic agents in beast carcinoma xenografts

Authors: Nasim Vahidfar / Amir R. Jalilian / Yousef Fazaeli / Ayuob Aghanejad / Ali Bahrami-Samani/ Behrooz Alirezapour/ Mostafa Erfani / Davood Beiki/ Ali Khalaj

Radiochimica Acta, Vol.102, No.7, Year. 2013, Page:29,

20. Synthesis, in vitro aerobic and hypoxic cytotoxicity and radiosensitizing activity of novel metronidazole tethered 5-fluorouracil

Authors: Khosrou Abdi , Ali khalaj , Seyed Nasser Ostad, Navid Lamei , Mohammad Reza Khoshayand

DARU Journal of Pharmaceutical Sciences, Year. 2013,

21. Radiosynthesis and Quality Control of [67Ga]-3,4-dimethoxylated Porphyrin Complex as a Possible Imaging agent

Authors: Azadeh Paknafas, Yousef Fazaeli, Amir Reza Jalilian, Abbas Ahmadi, Shahzad Feizi, Mohsen Kamalidehghan, Ali Rahiminejad, Ali Khalaj

Iranian Journal of Pharmaceutical Research, Vol.12, Year. 2013,

22. Synthesis, In Vitro Cytotoxicity and Radiosensitizing Activity of Novel 3-[(2,4-Dinitrophenylamino)Alkyl] Derivatives of 5-Fluorouracil

Authors: Ali Khalaj, Khosrou Abdi, Seyed Nasser Ostad, Mohammad Reza Khoshayand, Navid Lamei, Hasan Ali Nedaie

Chemical Biology & Drug Design, Year. 2013,

23. Development and evaluation of a 166holmium labelled porphyrin complex as a possible therapeutic agent

Authors: Nassim Vahidfar , Amir R. Jalilian , Yousef Fazaeli, Ali Bahrami-Samani, Davood Beiki , Ali Khalaj

Radioanal Nucl Chem, Vol.295, Year. 2013,

24. In Vitro and In Vivo Evaluation of Poly(Caprolactone Fumarate) Nanoparticles

Authors: N. Shokri, E. Azizi, H. Akbari Javar, Sh. Fouladdel, A. Khalaj, R. Dinarvand

IJPSR, Vol.3, Year. 2012,

25. Cytotoxicity and radiosensitising activity of synthesized dinitrophenyl derivatives of 5-fluorouracil

Authors: Khosrou Abdi, Ali Khalaj, Syeed-Naser Ostad,Mohammad Reza Khoshayand

DARU Journal of Pharmaceutical Sciences, Vol.20, Year. 2012,

26. Interaction of 5-Fluorouracil and its derivatives with bovine serum albumin

Authors: Abdi K, Nafisi Sh, Manouchehri F, Bonsaii M, Khalaj A

Photochem Photobiol B, Vol.107, Year. 2012,

27. Preparation and evaluation of poly(caprolactone fumarate) nanoparticles containing doxorubicin HCl

Authors: N Shokri, H Akbari Javar, Sh Fouladdel, A Khalaj, MR Khoshayand, R Dinarvand, F Atyabi, A Nomani, E Azizi,

DARU, Vol.1, Year. 2011, Number of Page:12-22

28. KhalajThe impact of substituentson isatin ring on the reaction between isatins with ortho-phenylenediamine

Authors: R. Dowlatabadi, A.Khalaj

Syn.Communi, Vol.41, Year. 2011, Number of Page:1650-1658

29. ForoumadiDiscovery of a novel nitroimidazolyleoxazolidinone hybrid with potent anti Gram-positive activity: Synthesis and pp. 1e6 antibacterial evaluation

Authors: Khalaj, M.Nakhjiri, A S. Negahbani, M.Samadizadeh, L. Firoozpour, SRajabalian, N.Samadi,M. AFaramarzi, N.Adibpour, A. Shafiee, AR

Eur J Med Chem , Vol.46, Year. 2011, Number of Page:65-70

30. Preparation and characterization of crosslinked and non-crosslinked polycaprolactone fumarate (PCLF) NPs as carriers for doxorubicin HCl

Authors: Narges Shokri, Hamid Akbari Javar, Shamileh Fouladdel, Ali Khalaj, Rasoul Dinarvand and Ebrahim Azizi

African Journal of Pharmacy and Pharmacology, Vol.5, No.7, Year. 2011, Number of Page:797-805

31. Synthesis and cytotoxicity of some biurets against human breast cancer T47D cell line

Authors: S.Fouladdel, A.Khalaj, N.Adibpour, E.Azizi

Bioorg Med Chem Lett, Vol.20, No.5772, Year. 2010,

32. .Initial and delayed stress phase imaging in a single-injection double-acquisition SPECT

Authors: D.Beiki,B.Fallahi, Z.Mohseni, A.Khalaj, A.Fard-Esfahani,M.Eftekhari

Schattauer, Vol.19, Year. 2010, Number of Page:19-27

33. Synthesis and antibacterial activity of isothiazolyl oxazolidinones and analogous 3(2H) isothiazolones

Authors: N.Adibpour, A.Khalaj, A.Rajabalian

Eur J Med Chem , Vol.45, Year. 2010, Number of Page:19-24

34. Synthesis and radioprotective study of novel amino-alkyldithiocarbamic acid derivatives against – irriadiation in mice

Authors: S.J.Hosseinimehr,D.Beiki, A.Kebriaeezadeh, A.Khalaj,M.Pirali,Hammedani,,S.Akhlaghpour, H.Esmaeili, A.R.Barazesh

Iran.J.Radiat.Res, Vol.7, No.2, Year. 2009, Number of Page:91-96

35. Investigation of Selective Cytotoxicity and Determination of Ligand Induced Apoptosis of a New Acenaphto[1,2-b] Quinoxaline Derivatives

Authors: E. Mahjoob, A. Khalaj, S.N. Ostad S.N, E .Azizi E, Fouladdel S, Tavajohi S, Salehi R, Dowlatabadi R

Arzneimittel Forschungmg , Vol.59, Year. 2009, Number of Page:526-531

36. Correlation between lipophilicity and antimicrobial activity of some 2-(4-substituted phenyl )-3(2H)-isothiazolones

Authors: S. Rezaee, A. Khalaj, N. Adibpour, M. Saffary

DARU, Vol.17, Year. 2009, Number of Page:263

37. Medicinal Chemistry

Authors: A.Safiee, A.Khalaj, K.Javidnia, H.Sadeghi-aliabadi, M.Amanloo, R.Miri

انتشارات دانشگاه علوم پزشكي شيراز, Vol.1, Year. 2009,

38. Synthesis and Evaluation of in vitro Anti-tuberculosis Activity of N-Substituted Glycolamides

Authors: F. Daryaee ,F.Kobarfard A Khalaj, P. Farnia

Eur J Med Chem, Vol.44, Year. 2009, Number of Page:289-295

39. Ultrasound promoted N-alkylation and N-acylation of 2,4-dinitro-phenylamine

Authors: A.Khalaj, A.R.Doroudi, N.Adibpour, J.Mohseni

Asian.J.Chem , Vol.21, Year. 2009, Number of Page:997-1001

40. Formation And Ring Contraction Of 1,2- Benzothiazepine-1,1 Dioxides From And To 1,2-Benzothiazine-1,1-Dioxides, Syn

Authors: A.khalaj, N.Adibpour

Communi, Vol.38, Year. 2008, Number of Page:3662-3671

41. Between Different Lipophilicity Parameters And Antimycobacterial Activities Of 2-Hydroxyacetamides

Authors: F. Kobarfard, A. Khalaj, F.Daryaee, Z. Ardeshir Larijany, S. RezaeeCorrelation

DARU, Vol.16, Year. 2008, Number of Page:55-59

42. Textbook of Nuclear Pharmacy

Authors: F.Atyabi,M.H.Babaei, D.Beiki, A.Cheraghali,R. Dowlatabadi-Bazaz, K.Haghir-Ebrahimabadi, S.J.Hosseinimehr, A.R.Jalilian, F. Johari, A.Khalaj, R.Najafi, A,Owlia.,

انتشارات دانشگاه علوم پزشكي تهران, Year. 2007,

43. Simple Synthesis of Radioiodinated N-Succinimidyl -4-Iodobenzoate:An Intermediate compound for the indirect radioiodination of antibodies, Eur

Authors: D.Beiki ,B.Fallahi, A.Khala

J. Nucl.Med, Vol.34, No.330, Year. 2007,

44. In vitro Antifungal Activity of Isothiazolone 3-ones

Authors: A.khalaj, N.Adibpour

Folia Microbiol , Vol.52, No.573, Year. 2007,

45. Qualitative assessment of the views of graduate and undergraduate students of the faculty of pharmacy about pharmaceutical research in Iran

Authors: A . Khalaj, K.Shokraiee, P.Seyfi, B.Mesgarpour, H.R Adhami;

Hakim, Vol.9, No.45, Year. 2006,

46. A theory of mode of action of azolylalkylquinolines as DNA binding agents using Automated flexible ligand docking

Authors: A. Madadkar Sobhani, S. Rasoul Amini , J. D.A. Tyndall , E. Azizi , M. Daneshtalab , A. Khalaj

J Mol Graph Model , Vol.25, No.459, Year. 2006,

47. Anti-Tumor Activity of New Quinoline Derivatives in Human Breast Cancer T47D Cells

Authors: S.Rasoul-Amini, A.Khalaj, A.Shafiee, M.Daneshtalab, A.Madadkar-Sobhani, S.Fouladdel, E.Azizi

Int J Canc Res , Vol.2, No.102, Year. 2006,

48. Synthesis, aerobic cytotoxicity, and radiosensitizing activity of novel 2,4-dinitrophenylamine tethered 5-fluorouracil and hydroxyurea

Authors: A.Khalaj , A. R .Doroudi ,S. Ostad, M. R. Khoshayand, M. Babai ,N.Adibpour

Bioorg Med Chem Lett, Vol.16, No.6034, Year. 2006,

49. Radipharmaceutical Regulation World Wide - the Resemblances and the Differences

Authors: R.Dowlatabadi Bazaz, D.Beiki, A.Khalaj

Iran J Nucl Med , Vol.21, No.23, Year. 2005,

50. Synthesis and Antimycobacterial Activity of 2-Hydroxyacetamides

Authors: F.Daryaee, F.Kobarfard, A.Khalaj, P.Farnia;

Daru, Vol.13, No.94, Year. 2005,

51. Validation of 13C-Urea Breath Test with Non Dispersive Isotope Selective Infrared Spectroscopy for the Diagnosis of Helicobacter Pylori Infection: A Survey in Iranian Population

Authors: D.Beiki, A.Khalaj, R.Dowlatabadi Bazaz, M.Eftekhari, M.H.Al-Seyed Hossein, A.Fard, B.Fallahi, M.R.Khoshayand;

Daru, Vol.13, No.52, Year. 2005,

52. Microdose 14C Urea Breath Test for the Diagnosis of Helicobacter Pylori/ A Survey in Iranian Population

Authors: R.Dowlatabadi Bazaz, A.Khalaj, D.Beki, M.Eftekhari, M.H.Al-Seyed Hosein, M.R.Khoshayand;

Daru, Vol.13, No.6, Year. 2005,

53. Synthesis and Antibacterial Activity of 2-(4-Substituted Phenyl)- 3(2H)-Isothiazolones

Authors: A.Khalaj, N.Adibpour, A.Shahverdi, M.Daneshtalab

Eur J Med Chem , Vol.39, No.699, Year. 2004,

54. Inhibitation and Activation Studies of Histidine Decarboxylase From Lactobacillus 30a By Imidazolidine 4-One Derivatives Using A pH-Stat Technique

Authors: B.Farzami, A.Ghassemieh, E.Elmi Akhoundi, A.Khalaj , R.Dowlatabadi;

Iranian J Sci Tech Transaction A, Vol.27, Year. 2003,

55. Synthesis of radioiodinated labeled peptides

Authors: M.Matloobi, H.Rafii, D.Beigi, M.Kamali-Dehghan

Journal of Radioanalytical an Nuclear Chemistry, Vol.257, No.71-73, Year. 2003,

56. Increased selectivity in inflammatory site identification via labelling of IgG with N-succinimidyl-4-[125I]iodobenzoate

Authors: Davood Beiki, Soraya Shahhosseini, Ali Khalaj, Mohammad Eftekari;

J Label Compd Radiopharmacy , Vol.45, No.1, Year. 2002,

57. Synthesis of N-(2, 3-dihydro-1-[14 C] methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)- benzamide and N-(2,3- dihydro-1-[14C]methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-N-[14C]methyl-benzamide as novel carbon-14 labelled CCK antagonists

Authors: Hojatollah Matloubi, Ali Khalaj, Reza Dowlatabadi, Gholamhossein Sirvani

J Label Compd Radiopharmacy, Vol.45, No.347, Year. 2002,

58. The antinociceptive and anti-inflammatory activities and lack of olcerogenicity of a benzodioxine -4- one and its analogous benzoxazine as cyclic acetal like derivatives of salicylic acid and salicylamide in mice and rats

Authors: A.Khalaj, M. Abdollahi, A. Kebriaee Zadeh, N. Adibpour, Z. Pandi, S. Rasoulamini

Indian J Pharmacol , Vol.34, No.184, Year. 2001,

59. NMR evidence for cationic behaviour of the benzotriazole ring in novel a- ( benzotriazol –1-yl ) –N-acylglycines

Authors: A.Khalaj, M. Pirali, R. Dowlatabadi

J Chem Research, Vol.412, Year. 2001,

60. A New and Simple Synthesis ofN-Succinimidyl- 4- [ 127 ,125 I ] Iodobenzoate Involving A Microwave - Accelerated Iodination

Authors: A. Khalaj, D. Beiki, H. Rafiee, R. Najafi

J Labelled Compounds and Radiopharm , Vol.44, No.235, Year. 2001,

61. A Short and Efficient Synthesis of Novel N ( 2,3-dihydro-2-oxo-5-phenyl -1H -1,4 -benzodizepin -3-yl ) -2- carboxamide

Authors: A. Khalaj, M. Pirali, H. Matloubi, R. Dowlatabadi;

Monatshefte fur Chemi , Vol.32, No.747, Year. 2001,

62. Effects of Acute and Chronic Lithium on Morphine Induced Analgesia in Mice by Formalin Tes

Authors: M. Sharifzadeh, H.R. Sadeghipour, F. Khjou, A. Khalaj, M. Abdollahi

Acta Medica Iranica , Vol.37, No.37, Year. 1999,

63. Molecular Modelling and Hypothermie Activity of Dantrolene Sodium and two Corresponding Analogues

Authors: A. Khalaj, M. Sharifzadeh, H. Shadnia

Pharm Pharmacol Commun , Vol.5, No.91, Year. 1999,

64. Ring Contraction of 3- Carboxamide or 3-Carboxylate of 4-Hydroxy-2-Methyl-2H-1,2-Benzothiazin-1,1-Dioxide and Analogous 1(2H)-Iso- quinoline-3-Carboxylate

Authors: A. Khalaj, N.Adibpour

Heterocycles, Vol.51, No.131, Year. 1999,

65. Synthesis, Molecular Modeling and In-Vitro Antibacterial Activity of 4- Amino- a- hydroxybenzeneacetamides

Authors: A. Khalaj, H. Shadnia, M.Sharifzadeh

Pharm Pharmacol Commun , Vol.4, No.373, Year. 1998,

66. Cyclic Acetal-Like Derivaties of Diclofenac; Synthesis and In-Vivo Evaluation in Rats

Authors: A.Khalaj, M. Amanlou, M.Jorjani

Pharm Pharmacol Commun , Vol.4, No.201, Year. 1998,

67. A New Synthesis ofa-HydroxyCarboxylates and 2-Hydroxybenzoates

Authors: A. Khalaj, R. Aboofazeli

Iran J Chem & Chem Eng , Vol.16, No.1, Year. 1997,

68. Synthesis of Novel Imidazolidinones

Authors: A. khalaj, R.D. Bazaz, M. Shekarchi

Monashefte Fur Chemie , Vol.128, No.395, Year. 1997,

69. Synthesis and Photo physical Properties of Fluorescent 2-Aryl-1, 3-Dialkylbenzimidazolium Ions and1-Alkyl-2-Arylbenzimidazoles with Excited State Intramolecular Proton Transfer

Authors: J.M. Kauffman, A.Khalaj, P.T. Litiak, J.A. Novinski, G.S.Gajwa

J Heterocycl Chem , Vol.31, No.957, Year. 1994,

70. New Synthesis of Unsubstituted 4 (5) and 4,5-Substituted1-H-imidazoles

Authors: A.Khalaj, M.Ghaffari

Tet Lett , Vol.27, No.50, Year. 1986,

71. Synthesis ofa- Hydroxy acid amides from Acetonides of a-Hydroxy acids and Amines

Authors: A.Khalaj, E. Nahid;

Synthesis , Vol.12, No.1153, Year. 1985,

72. Structure - Activity Relationship of 2, 3-Dihydro-1, 4-Benzothiazines.Iran

Authors: A. Khalaj;

J. Chem & Chem Eng , Vol.5, No.20, Year. 1985,

73. Studies on the Chemistry of Pharmacologically Active Heterocyclic.Part I, Acid Hydrolysis of Hydrazino-1, 2, 4- triazine- derivatives

Authors: M. Daneshtalab, A. Khalaj, and I. Lalezari

J. Heterocyclic. Chem, Vol.16, No.817, Year. 1979,

74. Electrochemical Evidence for Interaction between Chlorpromazine Hydrochloride and Trifluoperazine Hydrochloride and the Flavin Coenzymes

Authors: L.A. Delisser-Matthews , A. Khalaj;

J. Pharm. Sci, Vol.65, No.1758, Year. 1976,

1. Isothiazolones

2. (Synthesis and biological activity of 3(2H

3. Radiosensythizers

4. Prodrugs